<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000367459"><TermName>Triapine</TermName><TermPronunciation>(TRY-uh-peen)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of cancer. It is a type of ribonucleotide reductase inhibitor. Also called 3-aminopyridine-2-carboxaldehyde thiosemicarbazone and 3-AP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731293" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Triapine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731292" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Triapine&quot;" language="es" id="_4"/><SpanishTermName>Triapine</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un tipo de inhibidor del ribonucleótido reductasa. También se llama 3-aminopiridina-2-carboxaldehído tiosemicarbazona y 3-AP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-04-23</DateFirstPublished><DateLastModified>2007-01-17</DateLastModified></GlossaryTerm>
